 |
PDBsum entry 1rim
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
De novo protein
|
PDB id
|
|
|
|
1rim
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
43:7421-7431
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.
|
|
Y.Liu,
Z.Liu,
E.Androphy,
J.Chen,
J.D.Baleja.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The E6 protein from HPV type 16 binds proteins containing a seven-residue
leucine-containing motif. Previous work demonstrated that peptides containing
the consensus sequence are a mixture of alpha-helix and unstructured
conformations. To design monomeric E6-binding peptides that are stable in
aqueous solution, we used a protein grafting approach where the critical
residues of the E6-binding motif of E6-associated protein, E6AP, LQELLGE, were
incorporated into exposed helices of two stably folded peptide scaffolds. One
series was built using the third zinc finger of the Sp1 protein, which contains
a C-terminal helix. A second series was built using a Trp-cage scaffold, which
contains an N-terminal helix. The chimeric peptides had very different
activities in out-competing the E6-E6AP interaction. We characterized the
peptides by circular dichroism spectroscopy and determined high-resolution
structures by NMR methods. The E6-binding consensus motif was found to be
helical in the high-quality structures, which had backbone root-mean-square
deviations of less than 0.4 A. We have successfully grafted the E6-binding motif
into two parent peptides to create ligands that have biological activity while
preserving the stable, native fold of their scaffolds. The data also indicate
that conformational change is common in E6-binding proteins during the formation
of the complex with the viral E6 protein.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.S.Tungteakkhun,
M.Filippova,
N.Fodor,
and
P.J.Duerksen-Hughes
(2010).
The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.
|
| |
J Virol,
84,
1453-1463.
|
 |
|
|
|
|
 |
A.Irback,
S.Mitternacht,
and
S.Mohanty
(2009).
An effective all-atom potential for proteins.
|
| |
PMC Biophys,
2,
2.
|
 |
|
|
|
|
 |
A.Verma,
and
W.Wenzel
(2009).
A free-energy approach for all-atom protein simulation.
|
| |
Biophys J,
96,
3483-3494.
|
 |
|
|
|
|
 |
E.Gallicchio,
K.Paris,
and
R.M.Levy
(2009).
The AGBNP2 Implicit Solvation Model.
|
| |
J Chem Theory Comput,
5,
2544-2564.
|
 |
|
|
|
|
 |
J.Wei,
Y.Liu,
K.Bose,
G.D.Henry,
and
J.D.Baleja
(2009).
Disorder and structure in the Rab11 binding domain of Rab11 family interacting protein 2.
|
| |
Biochemistry,
48,
549-557.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Li,
S.Liang,
M.M.Pilcher,
and
S.O.Meroueh
(2009).
Incorporating receptor flexibility in the molecular design of protein interfaces.
|
| |
Protein Eng Des Sel,
22,
575-586.
|
 |
|
|
|
|
 |
S.Liang,
L.Li,
W.L.Hsu,
M.N.Pilcher,
V.Uversky,
Y.Zhou,
A.K.Dunker,
and
S.O.Meroueh
(2009).
Exploring the molecular design of protein interaction sites with molecular dynamics simulations and free energy calculations.
|
| |
Biochemistry,
48,
399-414.
|
 |
|
|
|
|
 |
Y.Liu,
J.J.Cherry,
J.V.Dineen,
E.J.Androphy,
and
J.D.Baleja
(2009).
Determinants of stability for the E6 protein of papillomavirus type 16.
|
| |
J Mol Biol,
386,
1123-1137.
|
 |
|
|
|
|
 |
D.V.Williams,
B.Barua,
and
N.H.Andersen
(2008).
Hyperstable miniproteins: additive effects of D- and L-Ala mutations.
|
| |
Org Biomol Chem,
6,
4287-4289.
|
 |
|
|
|
|
 |
O.Zimmermann,
and
U.H.Hansmann
(2008).
Understanding protein folding: small proteins in silico.
|
| |
Biochim Biophys Acta,
1784,
252-258.
|
 |
|
|
|
|
 |
S.S.Tungteakkhun,
M.Filippova,
J.W.Neidigh,
N.Fodor,
and
P.J.Duerksen-Hughes
(2008).
The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.
|
| |
J Virol,
82,
9600-9614.
|
 |
|
|
|
|
 |
S.S.Tungteakkhun,
and
P.J.Duerksen-Hughes
(2008).
Cellular binding partners of the human papillomavirus E6 protein.
|
| |
Arch Virol,
153,
397-408.
|
 |
|
|
|
|
 |
J.A.Kritzer,
R.Zutshi,
M.Cheah,
F.A.Ran,
R.Webman,
T.M.Wongjirad,
and
A.Schepartz
(2006).
Miniature protein inhibitors of the p53-hDM2 interaction.
|
| |
Chembiochem,
7,
29-31.
|
 |
|
|
|
|
 |
J.D.Baleja,
J.J.Cherry,
Z.Liu,
H.Gao,
M.C.Nicklaus,
J.H.Voigt,
J.J.Chen,
and
E.J.Androphy
(2006).
Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.
|
| |
Antiviral Res,
72,
49-59.
|
 |
|
|
|
|
 |
S.Mohanty,
and
U.H.Hansmann
(2006).
Folding of proteins with diverse folds.
|
| |
Biophys J,
91,
3573-3578.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |